[Modulation of the cholesteryl ester transfer protein: new perspectives for the management of cardiovascular risk]
{{output}}
Despite the widespread use of lipid-lowering therapies, a significant proportion of patients with atherosclerotic cardiovascular disease fail to achieve the recommended LDL-cholesterol targets, thus remaining at high residual risk. Inhibition of cholesteryl es... ...
